Abstract
Present therapy of inflammatory bowel diseases (IBDs) is aimed at relieving inflammation and treating signs and symptoms. Therapy consists of non-specific anti-inflammatory agents, such as 5-aminosalicylic acid, glucocorticoids, immunomodulators and anti-TNF ther-apy. The goals of therapy should include the induction and maintenance of remis-sion and an attempt to heal the mucosa with the ultimate goal being restitution of normal intestinal function. Despite an optimized use of immunosuppressors and the new biologic agents, the need for intes-tinal resection in Crohn’s disease (CD) has remained stable
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
